相关产品推荐更多 >

VIM抗体VIM兔多抗抗体Vimentin antibody抗体VIM Antibody, Biotin conjugated抗体
¥880
MYH1抗体MYH1兔多抗抗体skeletal muscle antibody抗体MYH1 Antibody抗体
¥440
TRAPPC9抗体TRAPPC9兔多抗抗体Tularik gene 1 protein antibody抗体TRAPPC9 Antibody抗体
¥440
HIST1H3A抗体HIST1H3A兔多抗抗体Histone H3/l antibody抗体Di-methyl-HIST1H3A (K9) Antibody抗体
¥660
SCN11A抗体SCN11A兔多抗抗体Voltage-gated sodium channel subunit alpha Nav1.9 antibody抗体SCN11A Antibody, HRP conjugated抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发,品质稳、品类全,实验不再等!Takara 秋促来袭,提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ¥1200阿拉丁 22万+ 科研级产品现货速发,品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Synthesized peptide derived from the N-terminal region of Human LTβR.
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
Upon receipt, store at -20℃ or -80℃. Avoid repeated freeze.
- 克隆性:
/
- 标记物:
Non-conjugated
- 适应物种:
Human,Mouse
- 保质期:
6个月
- 抗原来源:
Homo sapiens (Human)
- 目录编号:
P36941
- 级别:
优
- 库存:
200
- 供应商:
武汉华美生物工程有限公司
- 宿主:
Rabbit
- 应用范围:
WB, IF, ELISA; WB:1:500-1:2000, IF:1:200-1:1000, ELISA:1:40000
- 浓度:
>95%,The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 靶点:
LTBR
- 抗体英文名:
LTBR Antibody
- 抗体名:
Tumor necrosis factor receptor type III antibody
- 规格:
100μg/50μg
| 规格: | 100μg | 产品价格: | ¥1320.0 |
|---|---|---|---|
| 规格: | 50μg | 产品价格: | ¥880.0 |
保存缓冲液
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.功能
/风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Collagen-Induced Arthritis in Mice: A Major Role for Tumor Necrosis Factor-
arthritis, including tumor necrosis factor-α (TNFα) and interleukin (IL)-1β, IL-6, IL-1Ra, IL-10, and transforming growth factor β. The use transgenic and knockout strains of mice, as well as biological inhibitors, have revealed important pathological roles
. We isolated a variant of Herceptin, a therapeutic monoclonal antibody that binds the human epidermal growth factor receptor 2 (HER2), on the basis of its ability to simultaneously interact with vascular endothelial growth factor (VEGF). Crystallographic
2141-V11瘤内给药2例CR、Dapirolizumab III期BICLA 50%:CD40在2026年交出怎样的答卷
方向。CMTM6-CD40轴的发现则提示,CD40的膜稳定性本身就是一个可调控节点,为联合策略提供了新的生物学接口。 5. CD4相关研究产品推荐 ● CD40重组蛋白: Recombinant Human Tumor necrosis factor receptor superfamily member 5 (CD40), partial (Active); CSB-MP004936HU1 Recombinant Mouse Tumor necrosis factor receptor
技术资料暂无技术资料 索取技术资料






